Sarah K. Nelson-Taylor

Pediatrics
13001 E 17th Pl
Aurora, CO 80045

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications

Glomerular Transcriptome Analysis Reveals Endothelial Disturbances in Patients With Idiopathic Nephrotic Syndrome.

Glomerular Transcriptome Analysis Reveals Endothelial Disturbances in Patients With Idiopathic Nephrotic Syndrome.

Journal: Kidney medicine
Published: February 09, 2026

Single-Cell RNA Sequencing of Ewing Sarcoma Tumors Demonstrates Transcriptional Heterogeneity and Clonal Evolution.

Single-Cell RNA Sequencing of Ewing Sarcoma Tumors Demonstrates Transcriptional Heterogeneity and Clonal Evolution.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 28, 2024

Characterization of transcriptional heterogeneity and novel therapeutic targets using single cell RNA-sequencing of primary and circulating Ewing sarcoma cells.

Characterization of transcriptional heterogeneity and novel therapeutic targets using single cell RNA-sequencing of primary and circulating Ewing sarcoma cells.

Journal: bioRxiv : the preprint server for biology
Published: January 31, 2024

Cadherin-11 contributes to the heterogenous and dynamic Wnt-Wnt-β-catenin pathway activation in Ewing sarcoma.

Cadherin-11 contributes to the heterogenous and dynamic Wnt-Wnt-β-catenin pathway activation in Ewing sarcoma.

Journal: PloS one
Published: July 01, 2023

A functional sgRNA-CRISPR screening method for generating murine RET and NTRK1 rearranged oncogenes.

A functional sgRNA-CRISPR screening method for generating murine RET and NTRK1 rearranged oncogenes.

Journal: Biology open
Published: May 03, 2023

A Rapid, Functional sgRNA Screening Method for Generating Murine RET and NTRK1 Fusion Oncogenes.

A Rapid, Functional sgRNA Screening Method for Generating Murine RET and NTRK1 Fusion Oncogenes.

Journal: bioRxiv : the preprint server for biology
Published: April 17, 2023

Resistance to RET-Inhibition in RET-Rearranged NSCLC Is Mediated By Reactivation of RAS/MAPK Signaling.

Resistance to RET-Inhibition in RET-Rearranged NSCLC Is Mediated By Reactivation of RAS/MAPK Signaling.

Journal: Molecular cancer therapeutics
Published: January 03, 2017
Showing 1-7 of 7

Last Updated: 09/26/2026